Abiopharma

Clinical trial NCT05419479 updates: 1. completion date: 2028-09-30 → 2032-05-17 2. primary completion date: 2027-01-31 → 2026-05-17

Clinical trial NCT07617961: completion date: 2026-05-21 → 2027-05-21.

Clinical trial NCT05992480 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-05-01 → 2026-11-01 3. primary completion date: 2026-05-01 → 2026-11-01 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05575492 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2027-01-15 → 2026-05-12 3. primary completion date: 2027-01-15 → 2026-05-12

Clinical trial NCT05959083 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-06-01 → 2026-05-07 3. primary completion date: 2026-06-01 → 2026-05-07

Clinical trial NCT07583563 updates: 1. start date: 2026-05-01 → 2026-06-01 2. completion date: 2029-05-01 → 2029-06-01 3. primary completion date: 2029-05-01 → 2029-06-01

Clinical trial NCT06548555: enrollment: 120 → 121 participants.

Clinical trial NCT07562152: start date: 2026-05-01 → 2026-06-01.

FULC Investor Alert: Levi & Korsinsky Investigates Fulcrum Therapeutics, Inc. (FULC) for Potential Securities Fraud

NetApp与Cisco携手强化企业级网络韧性的纵深防御体系